AGP Picks
View all

Get your daily news on science and technology

Provided by AGP

Technology, Science, & Me!: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology, Science, & Me!.

Press releases published on May 8, 2026

Acronis y NetFusion #TeamUp se asocian para lanzar un laboratorio de robótica STEAM para estudiantes vulnerables en Costa Rica
SalesCloser Announces Collaboration with Twilio to Accelerate Customer Deployments
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ParaZero Announces Receipt of Nasdaq Minimum Bid Price Notification
Azalea Therapeutics Announces Late-Breaking Oral Presentation at ASGCT Annual Meeting Demonstrating First-in-Primate In Vivo TRAC-CAR T Cell Engineering
NVIDIA Names Suzanne Nora Johnson to Board of Directors
From Iconic Expeditions to Modern Mobility as FREELANDER Reinvents the Spirit of Land Rover DNA
Koryx Copper Files Technical Report with Updated Mineral Resource Estimate for the Haib Copper Project,  Southern Namibia
FDA Issues Guidance to Improve Collection of Pregnancy Safety Data for Drugs and Biologics
Capnos Legura 2026: Claims Examined, Pricing Verified & What Consumers Should Confirm Before Buying
Industry Insights Reveal Key Considerations for Using Grease with O-Rings in Vacuum Systems
Accurate Quantification of Bacterial Endotoxins Using BETMAT’s Kinetic Chromogenic LAL Assay
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
ICZOOM Group Inc. Announces Change to Extraordinary General Meeting Schedule
KULR Technology Group Sets First Quarter 2026 Earnings Call for Thursday, May 14, 2026 at 4:30 p.m. ET
Startups Are Moving Beyond No-Code Platforms, Why Businesses Are Returning to Professional Design & Development Agencies
Entera Announces First Quarter 2026 Financial Results and Updates Across its Oral Peptide Programs
Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Longeveron Announces Constructive Type C Meeting with U.S. FDA Ahead of Data Readout for ELPIS II Phase 2b Clinical Trial Evaluating Treatment for Hypoplastic Left Heart Syndrome (HLHS)

Share us

on your social networks:

Sign up for:

Technology, Science, & Me!

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.